ALEMBIC Latest Share Price (ALEMBICLTD)
TODAY IN ONE LINE
ALEMBICLTD fell 2.0% on above-average volume (1.6x avg), lagging Nifty's -0.3% move.
With a market cap of ₹2,696.21 Cr., it trades at a P/E of 8.41. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
ALEMBIC flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Return on EquityHealthy ROE of 15.2%
- ●Healthy Operating MarginsOPM is structurally strong at 64.0%
- ●Reasonable ValuationTrading at a moderate P/E of 7.4x
- ●High Promoter HoldingPromoters hold 70.9% skin-in-the-game
- ●Steady Dividend YieldReliable 2.29% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.01x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 2.2% YoY
- ●Rising Receivables vs SalesReceivables grew 58.4% outpacing sales growth of 40.9%
Latest ALEMBIC News
What changed recently?
Recent events, corporate actions, and announcements.
ALEMBIC valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for ALEMBIC, framed against the sector median so the premium or discount is obvious at a glance.
ALEMBIC trades at a P/E of 8.41× and P/B of 1.10×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
ALEMBIC technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for ALEMBIC — derived from the latest tape, not yesterday's close.
ALEMBIC last traded at ₹104.33 with an intraday range of ₹103.14–₹105.9 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹104.33| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 111.29 | +6.96 | +6.67% |
| R3 | 108.53 | +4.20 | +4.03% |
| R2 | 107.22 | +2.89 | +2.77% |
| R1 | 105.77 | +1.44 | +1.38% |
| PIVOT | 104.46 | 0.13 | 0.12% |
| CURRENT | 104.33 | — | — |
| S1 | 103.01 | -1.32 | -1.26% |
| S2 | 101.70 | -2.63 | -2.52% |
| S3 | 100.25 | -4.08 | -3.91% |
| S4 | 97.49 | -6.84 | -6.55% |
ALEMBICLTD is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹103.6–₹105.9
Trading Below opening range, showing Bearishness
ALEMBIC financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for ALEMBIC — consolidated or standalone — with margins, YoY growth and key ratios inline.
ALEMBIC reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,696.21 Cr. and reported EPS of ₹2.53.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 222 | 240 ▲ 8.2% |
| Sales Growth YoY %Derived | 40.89% | 8.16% |
| Other Income | 75 | 73 ▼ 2.6% |
| Total Income | 297 | 313 ▲ 5.5% |
| 9 | 16 ▲ 80.2% | |
| Gross ProfitDerived | 213 | 224 ▲ 5.1% |
| Gross Margin %Derived | 95.89% | 93.16% |
| 119 | 133 ▲ 11.8% | |
| EBITDA (Operating Profit)Derived | 94 | 90 ▼ 3.5% |
| OPM %Derived | 42.23% | 37.69% |
| 13 | 15 ▲ 12.0% | |
| Profit Before Tax (PBT) | 156 | 149 ▼ 4.3% |
| 11 | 23 ▲ 108.8% | |
| Effective Tax %Derived | 7.03% | 15.34% |
| Total Profit for Period | 311 | 317 ▲ 2.2% |
| Net Profit (Owner's PAT)Derived | 311 | 317 ▲ 2.2% |
| Net Profit Margin %Derived | 140.02% | 132.25% |
| PAT Growth YoY %Derived | 15.66% | 2.16% |
| Earnings Per Share (EPS ₹) | 12.10 | 12.36 ▲ 2.1% |
| Diluted Shares Outstanding (Cr) | 26 | 26 ▲ 0.0% |
| Share of Profit from Associates/JVs | 166 | 191 ▲ 15.3% |
| Other Comprehensive Income (Net of Tax) | -34 | -88 ▼ 155.1% |
| Total Expenses (incl. D&A & Interest) | 141 | 164 ▲ 16.2% |
| Material Cost % of RevenueDerived | 3.61% | 5.78% |
| Employee Cost % of RevenueDerived | 12.31% | 15.60% |
| Other Cost % of RevenueDerived | 41.35% | 39.86% |
| Interest Coverage (x)Derived | 33.62x | 34.27x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 125 | 128 ▲ 1.9% | 74 ▼ 42.1% | 74 ▼ 0.6% | 78 ▲ 6.4% | 127 ▲ 62.7% | 157 ▲ 23.8% | 222 ▲ 40.9% | 240 ▲ 8.2% | |
| Sales Growth YoY %Derived | — | 1.92% | -42.11% | -0.55% | 6.39% | 62.68% | 23.77% | 40.89% | 8.16% | |
| Other Income | 37 | 29 ▼ 20.4% | 93 ▲ 217.2% | 10 ▼ 89.0% | 89 ▲ 767.9% | 64 ▼ 27.9% | 55 ▼ 14.8% | 75 ▲ 36.7% | 73 ▼ 2.6% | |
| Total Income | 162 | 157 ▼ 3.2% | 167 ▲ 6.5% | 84 ▼ 49.9% | 167 ▲ 99.8% | 192 ▲ 14.4% | 212 ▲ 10.8% | 297 ▲ 39.8% | 313 ▲ 5.5% | |
79 | 45 ▼ 43.3% | 31 ▼ 29.6% | 9 ▼ 70.2% | 11 ▲ 17.1% | 6 ▼ 42.5% | 9 ▲ 44.8% | 9 ▼ 0.3% | 16 ▲ 80.2% | ||
| Gross ProfitDerived | 47 | 83 ▲ 78.4% | 42 ▼ 48.9% | 64 ▲ 50.9% | 67 ▲ 4.8% | 121 ▲ 79.9% | 148 ▲ 22.7% | 213 ▲ 43.4% | 224 ▲ 5.1% | |
| Gross Margin %Derived | 37.17% | 65.06% | 57.48% | 87.24% | 85.96% | 95.04% | 94.19% | 95.89% | 93.16% | |
35 | 62 ▲ 75.1% | 39 ▼ 36.8% | 53 ▲ 35.3% | 53 ▲ 0.5% | 81 ▲ 51.2% | 91 ▲ 13.5% | 119 ▲ 30.2% | 133 ▲ 11.8% | ||
| EBITDA (Operating Profit)Derived | 11 | 21 ▲ 89.1% | 3 ▼ 84.4% | 11 ▲ 237.6% | 14 ▲ 25.8% | 40 ▲ 189.5% | 57 ▲ 41.0% | 94 ▲ 64.8% | 90 ▼ 3.5% | |
| OPM %Derived | 8.86% | 16.44% | 4.44% | 15.06% | 17.81% | 31.70% | 36.11% | 42.23% | 37.69% | |
4 | 3 ▼ 27.9% | 4 ▲ 23.6% | 4 ▲ 22.4% | 5 ▲ 22.1% | -3 ▼ 165.1% | 9 ▲ 361.6% | 13 ▲ 46.4% | 15 ▲ 12.0% | ||
| Profit Before Tax (PBT) | 44 | 48 ▲ 7.8% | 93 ▲ 95.7% | 17 ▼ 81.7% | 98 ▲ 474.2% | 87 ▼ 11.3% | 103 ▲ 18.3% | 156 ▲ 51.4% | 149 ▼ 4.3% | |
2 | 4 ▲ 72.9% | 0 ▼ 96.8% | 3 ▲ 2344.5% | 12 ▲ 264.5% | 6 ▼ 47.0% | 10 ▲ 58.9% | 11 ▲ 11.3% | 23 ▲ 108.8% | ||
| Effective Tax %Derived | 5.42% | 8.70% | 0.14% | 18.78% | 11.92% | 7.12% | 9.56% | 7.03% | 15.34% | |
| Total Profit for Period | 163 | 230 ▲ 41.4% | 329 ▲ 42.8% | 343 ▲ 4.2% | 222 ▼ 35.2% | 191 ▼ 14.1% | 269 ▲ 40.9% | 311 ▲ 15.7% | 317 ▲ 2.2% | |
| Net Profit (Owner's PAT)Derived | 163 | 230 ▲ 41.4% | 329 ▲ 42.8% | 343 ▲ 4.2% | 222 ▼ 35.2% | 191 ▼ 14.1% | 269 ▲ 40.9% | 311 ▲ 15.7% | 317 ▲ 2.2% | |
| Net Profit Margin %Derived | 130.08% | 180.44% | 445.20% | 466.35% | 283.90% | 149.83% | 170.57% | 140.02% | 132.25% | |
| PAT Growth YoY %Derived | — | 41.39% | 42.82% | 4.17% | -35.23% | -14.14% | 40.90% | 15.66% | 2.16% | |
| Earnings Per Share (EPS ₹) | 6.10 | 8.97 ▲ 47.0% | 12.82 ▲ 42.9% | 13.35 ▲ 4.1% | 8.65 ▼ 35.2% | 7.42 ▼ 14.2% | 10.46 ▲ 41.0% | 12.10 ▲ 15.7% | 12.36 ▲ 2.1% | |
| Diluted Shares Outstanding (Cr) | 27 | 26 ▼ 3.8% | 26 ▲ 0.0% | 26 ▲ 0.0% | 26 ▲ 0.0% | 26 ▲ 0.0% | 26 ▲ 0.0% | 26 ▲ 0.0% | 26 ▲ 0.0% | |
| Share of Profit from Associates/JVs | 121 | 187 ▲ 54.3% | 236 ▲ 26.3% | 329 ▲ 39.4% | 136 ▼ 58.7% | 110 ▼ 19.0% | 176 ▲ 59.7% | 166 ▼ 5.5% | 191 ▲ 15.3% | |
| Other Comprehensive Income (Net of Tax) | 45 | 16 ▼ 63.4% | -17 ▼ 205.3% | 345 ▲ 2102.3% | 107 ▼ 69.0% | -214 ▼ 300.4% | -60 ▲ 72.1% | -34 ▲ 42.5% | -88 ▼ 155.1% | |
| Total Expenses (incl. D&A & Interest) | 118 | 110 ▼ 7.3% | 74 ▼ 32.3% | 67 ▼ 10.0% | 70 ▲ 4.2% | 105 ▲ 50.6% | 110 ▲ 4.6% | 141 ▲ 28.9% | 164 ▲ 16.2% | |
| Material Cost % of RevenueDerived | 56.37% | 35.40% | 33.27% | 16.01% | 10.90% | 5.44% | 5.47% | 3.61% | 5.78% | |
| Employee Cost % of RevenueDerived | 16.55% | 16.83% | 28.12% | 30.74% | 27.45% | 18.90% | 14.62% | 12.31% | 15.60% | |
| Other Cost % of RevenueDerived | 11.75% | 31.79% | 24.93% | 41.45% | 40.70% | 44.44% | 43.47% | 41.35% | 39.86% | |
| Interest Coverage (x)Derived | 43.25x | 84.97x | 0.18x | 19.69x | 23.30x | 72.22x | 44.22x | 33.62x | 34.27x |
ALEMBIC segment analysis : revenue and profit mix.
Disclosed business segments at ALEMBIC with their share of revenue and profit, switchable between consolidated and standalone reporting.
ALEMBIC discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for ALEMBIC.
Our AI distills the core fundamental drivers supporting ALEMBIC, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
ALEMBIC's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. Bedrock invocation timeout
Flip Conditions.
Valuation risk. a P/E above 11 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 10% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 1.15%.
ALEMBIC peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — ALEMBIC is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
ALEMBIC chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for ALEMBIC — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
ALEMBIC delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for ALEMBIC over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in ALEMBIC stood at 47.5% of traded volume, against a 20-day average of 45.7%.
ALEMBIC announcements: results, concalls, ratings, M&A.
Filings ALEMBIC sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
ALEMBIC files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 80 documents below.
Copy of Newspaper Publication
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Shareholders meeting
Alembic Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 11, 2026. Further, the company has…
Shareholders meeting
Alembic Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 11, 2026
Copy of Newspaper Publication
Alembic Limited has informed the Exchange about Copy of Newspaper Publication
Outcome of Board Meeting
Alembic Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
ALEMBIC dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue ALEMBIC has declared, sequenced by announce and record date.
ALEMBIC corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About ALEMBIC: business, sector, key facts.
What ALEMBIC does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
ALEMBIC operates in the Diversified Commercial Services industry under the Services sector, listed as NSE: ALEMBICLTD, BSE: 506235.
Alembic Limited is a diversified Indian company with a primary focus on two distinct segments: Active Pharmaceutical Ingredients (APIs) and real estate. Established in 1907 and headquartered in Vadodara, India, the company boasts a long history in the Indian business landscape. Its operations span both domestic and international markets, showcasing a significant reach within the industry.
The API segment of Alembic Limited involves the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients. This segment encompasses a robust research and development component, highlighting the company's commitment to innovation and improvement within the pharmaceutical sector. Alembic Limited supplies these APIs to pharmaceutical companies, representing a key role in the larger pharmaceutical supply chain.
Alembic's real estate business operates on multiple levels. The company undertakes the construction of both residential and commercial real estate projects across various locations. Beyond direct construction, it also provides project management and marketing consultancy services to other companies and individuals in the real estate sector. Furthermore, Alembic Limited actively engages in the leasing of commercial properties, generating revenue streams through rental income.
In addition to its core businesses in APIs and real estate, Alembic Limited also participates in power generation. This diversification extends to the utilization of co-generation plants and wind power sources, reflecting a commitment to sustainability and energy diversification. This aspect contributes to a more holistic and resilient business model, mitigating some of the inherent risks associated with relying solely on one or two primary sectors.
The company's client base is broad and includes individuals, corporations, business houses, and pharmaceutical companies. This diverse customer portfolio demonstrates Alembic's ability to cater to a wide range of needs within its respective market segments. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd., further solidifying its position within a larger corporate structure.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AJMERA REALTY & INF I (AJMERA) Share PricePeer
- AMJ LAND HOLDINGS (AMJLAND) Share PricePeer
- ANANT RAJ (ANANTRAJ) Share PricePeer
- ARIHANT SUPERSTRUCT (ARIHANTSUP) Share PricePeer
- ARKADE DEVELOPERS (ARKADE) Share PricePeer
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about ALEMBIC (ALEMBICLTD).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of ALEMBIC (ALEMBICLTD)?
The current share price of ALEMBIC (ALEMBICLTD) is ₹104.33. Today, the stock has declined by ₹2.17 (2.04%), trading in a range of ₹103.14 to ₹105.90. The stock opened at ₹105.32 with a trading volume of 6,98,680 shares.
02Is ALEMBIC stock a good investment for long-term?
ALEMBIC can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,696.21 Cr., P/E ratio of 8.41, ROE of 15.16%, and ROCE of 9.28%. The dividend yield stands at 2.29%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of ALEMBIC stock?
The 52-week high price of ALEMBIC (ALEMBICLTD) is ₹117.72, while the 52-week low is ₹70.46. Currently trading at ₹104.33, the stock is 48.07% above its 52-week low and 11.37% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy ALEMBIC stock at the current price?
Whether to buy ALEMBIC stock at ₹104.33 depends on multiple factors. The stock is currently trading with a P/E ratio of 8.41 and P/B ratio of 1.1. Today's performance shows a loss of 2.04%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of ALEMBIC and when is the next dividend?
ALEMBIC offers a dividend yield of 2.29%, which means for every ₹100 invested at the current price of ₹104.33, you can expect to receive approximately ₹2.29 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of ALEMBIC?
ALEMBIC's key financial metrics include: P/E Ratio: 8.41, P/B Ratio: 1.1, ROE: 15.16%, ROCE: 9.28%, Dividend Yield: 2.29%, EPS: ₹2.53, Book Value: ₹95.22, and Debt-to-Equity: 0.01. The company's market cap stands at ₹2,696.21 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is ALEMBIC stock performing today in the market?
ALEMBIC stock opened at ₹105.32 and is currently trading at ₹104.33, showing a decline of ₹2.17 (2.04%). The intraday high is ₹105.90 and low is ₹103.14. The trading volume stands at 6,98,680 shares, indicating moderate market participation today.
08What is the P/E ratio of ALEMBIC and what does it indicate?
ALEMBIC has a Price-to-Earnings (P/E) ratio of 8.41, which means investors are willing to pay 8.41 for every ₹1 of earnings. With an EPS of ₹2.53, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about ALEMBIC (ALEMBICLTD) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.